PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2023 · 68 positions · Total reported value $1.97B · Top-10 concentration 36.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, PFM Health Sciences, LP disclosed 68 equity positions with a combined reported value of $1.97B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 36.0% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were LLY ($160.41M), HUM ($80.79M), ABBV ($74.71M). By sector, the heaviest allocations are Health Care 83.6%, Industrials 3.8%.

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions.

The largest new positions opened in Q3 2023 were LLY ($160.41M), HUM ($80.79M), ABBV ($74.71M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • LLY ELI LILLY & CO · $160.41M
  • HUM HUMANA INC · $80.79M
  • ABBV ABBVIE INC · $74.71M
  • MRK MERCK & CO INC · $61.39M
  • SGEN SEAGEN INC · $59.75M
  • UNH UNITEDHEALTH GROUP INC · $58.52M
  • CAH CARDINAL HEALTH INC · $55.55M
  • CNC CENTENE CORP DEL · $54.41M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 83.6%
Technology 1.2%
Materials 0.4%
Other 11.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 298.64K $160.41M 8.13%
8.13%
New
2 166.07K $80.79M 4.09%
4.09%
New
3 501.19K $74.71M 3.79%
3.79%
New
4 596.26K $61.39M 3.11%
3.11%
New
5 281.62K $59.75M 3.03%
3.03%
New
6 116.07K $58.52M 2.97%
2.97%
New
7 639.78K $55.55M 2.82%
2.82%
New
8 789.87K $54.41M 2.76%
2.76%
New
9 213.56K $52.59M 2.67%
2.67%
New
10 104.73K $51.49M 2.61%
2.61%
New
11 172.04K $50.29M 2.55%
2.55%
New
12 702.59K $48.68M 2.47%
2.47%
New
13 186.63K $47.97M 2.43%
2.43%
New
14 143.78K $47.14M 2.39%
2.39%
New
15 192.41K $46.54M 2.36%
2.36%
New
16 485.47K $45.76M 2.32%
2.32%
New
17 679.08K $45.61M 2.31%
2.31%
New
18 175.69K $43.59M 2.21%
2.21%
New
19 97.50K $42.40M 2.15%
2.15%
New
20 836.57K $40.36M 2.05%
2.05%
New
21 153.96K $39.80M 2.02%
2.02%
New
22 201.04K $39.55M 2.00%
2.00%
New
23 2.72M $39.43M 2.00%
2.00%
New
24 578.70K $38.13M 1.93%
1.93%
New
25 523.21K $36.57M 1.85%
1.85%
New
26 1.16M $32.55M 1.65%
1.65%
New
27 6.72M $32.14M 1.63%
1.63%
New
28 62.14K $31.45M 1.59%
1.59%
New
29 250.97K $30.42M 1.54%
1.54%
New
30 318.77K $29.74M 1.51%
1.51%
New
31 119.53K $29.40M 1.49%
1.49%
New
32 2.22M $27.30M 1.38%
1.38%
New
33 377.87K $26.57M 1.35%
1.35%
New
34 372.76K $25.90M 1.31%
1.31%
New
35 1.41M $25.22M 1.28%
1.28%
New
36 118.91K $24.19M 1.23%
1.23%
New
37 138.21K $23.37M 1.19%
1.19%
New
38 25.00M $21.33M 1.08%
1.08%
New
39 6.04M $18.36M 0.93%
0.93%
New
40 472.54K $18.14M 0.92%
0.92%
New
41 8.92M $15.25M 0.77%
0.77%
New
42 15.00M $14.59M 0.74%
0.74%
New
43 1.22M $14.19M 0.72%
0.72%
New
44 869.89K $13.81M 0.70%
0.70%
New
45 200.00K $13.08M 0.66%
0.66%
New
46 4.20M $12.98M 0.66%
0.66%
New
47 90.51K $11.38M 0.58%
0.58%
New
48 214.30K $10.84M 0.55%
0.55%
New
49 1.61M $10.76M 0.55%
0.55%
New
50 24.53K $10.68M 0.54%
0.54%
New

FAQ

What did PFM Health Sciences, LP buy in 2023-Q3?

In its 2023-Q3 13F filing, PFM Health Sciences, LP reported 68 equity positions worth $1.97B in aggregate; its largest disclosed positions were LLY ($160.41M), HUM ($80.79M), ABBV ($74.71M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $1.97B of long equity holdings across 68 positions as of 2023-Q3. Top-10 holdings account for 36.0% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →